Virtual Reality in ICU - PARTNER
Launched by KIRBY MAYER · Mar 13, 2025
Trial Information
Current as of April 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The PARTNER clinical trial is exploring how virtual reality (VR) can help patients in the Intensive Care Unit (ICU) who are dealing with serious conditions like acute respiratory failure and sepsis. The goal is to see if using VR can make patients feel better while they are hospitalized. Participants in the study will engage in fun activities, like breathing exercises and brain games, designed to relax them and improve their well-being. The study will take about 5 days, with patients spending around 15 to 45 minutes each day using the virtual reality system.
To be eligible for this trial, participants must be at least 18 years old and admitted to the ICU at the University of Kentucky for acute respiratory failure, sepsis, or similar conditions. However, people with certain health issues, such as existing neurological disorders, emotional disorders, or those who are pregnant, cannot participate. This study offers a unique opportunity for eligible patients to experience a new way of coping during a challenging time in the ICU.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted to ICU at University of Kentucky for acute respiratory failure, sepsis or other
- Exclusion Criteria:
- • Are less than 18 years of age
- • Have a pre-existing neurologic disorder
- • Have a pre-existing emotional or personality disorder
- • Have a history or active mental health disorder or disease
- • Experienced an acute neurologic event (e.g., stroke)
- • Are currently pregnant
- • Are a prisoner
- • Receiving hospice care
- • Have existing open wounds or pressure ulcers on head or neck
About Kirby Mayer
Kirby Mayer is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a strong commitment to ethical standards and regulatory compliance, Kirby Mayer collaborates with leading healthcare professionals and institutions to design, implement, and manage clinical trials across various therapeutic areas. The organization emphasizes a patient-centric approach, leveraging cutting-edge technologies and methodologies to ensure the highest quality data collection and analysis. By fostering a culture of collaboration and transparency, Kirby Mayer aims to accelerate the development of safe and effective treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Patients applied
Trial Officials
Kirby P. Mayer, Ph.D.
Principal Investigator
University of Kentucky
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported